Get the Stockscreener App
0.3748
3.33%
-0.0129
After Hours:
.36
-0.0148
-3.95%
Geovax Labs Inc stock is traded at $0.3748, with a volume of 375.43K.
It is down -3.33% in the last 24 hours and down -24.72% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$0.3877
Open:
$0.392
24h Volume:
375.43K
Relative Volume:
0.49
Market Cap:
$11.13M
Revenue:
$6.14M
Net Income/Loss:
$-24.81M
P/E Ratio:
-0.1505
EPS:
-2.49
Net Cash Flow:
$-27.40M
1W Performance:
-0.61%
1M Performance:
-24.72%
6M Performance:
-67.12%
1Y Performance:
-84.38%
1-Day Range:
$0.3711
$0.392
1-Week Range:
$0.37
$0.4302
52-Week Range:
$0.365
$2.75
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.3748 | 11.52M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
Geovax Labs Inc Stock (GOVX) Latest News
New Mpox Variant Emergence Highlights Global Vaccine Supply Vulnerability, GeoVax Accelerates Domestic Alternative – citybuzz - citybuzz
GeoVax Addresses Identification of New Mpox Variant - TradingView — Track All Markets
GeoVax Strengthens Scientific Advisory Board with Global Vaccine Experts - citybuzz
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board - Yahoo Finance
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy - Yahoo Finance
GeoVax’s Gedeptin Shows Favorable Safety and Disease Stability in Recurrent Head & Neck Cancer Trial - citybuzz
GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer - Yahoo Finance
Insider Sell: How GeoVax Labs Inc stock reacts to bond yieldsJuly 2025 Trends & Weekly Top Performers Watchlists - moha.gov.vn
An analyst sees good growth prospects for Geovax Labs Inc (GOVX) - setenews.com
Can GeoVax Labs Inc. Equity Warrant stock continue upward trendMarket Performance Report & Long-Term Capital Growth Ideas - Newser
What analysts say about GeoVax Labs Inc stockMarket Insider Reports & Low Risk Trading Ideas - earlytimes.in
Is This the Dip to Buy in Globus Spirits LimitedRisk Management Strategies & Free Discover Breakout Stocks Early - earlytimes.in
GeoVax Labs Earnings Call: Vaccine Progress Amid Financial Challenges - MSN
Will GeoVax Labs Inc. stock return to pre crisis levelsQuarterly Portfolio Report & Proven Capital Preservation Methods - Newser
Geovax Labs (GOVX) Stock Analysis Report | Financials & Insights - Benzinga
Update Recap: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Macro Moves & Entry Point Confirmation Alerts - moha.gov.vn
Returns Recap: Will GeoVax Labs Inc. stock outperform Nasdaq indexRate Hike & Reliable Breakout Forecasts - BỘ NỘI VỤ
GeoVax Labs Approves Share Issuance and Reverse Split - TipRanks
GeoVax to Present at the Noble Capital Markets Twenty-First Annual Emerging Growth Equity Conference - Yahoo Finance
GeoVax Labs Inc. (GOVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
GeoVax Labs (NASDAQ:GOVX) Price Target Cut to $6.00 by Analysts at D. Boral Capital - Defense World
How resilient is GeoVax Labs Inc. Equity Warrant stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Should you wait for a breakout in GeoVax Labs Inc. Equity WarrantMarket Volume Report & Expert Curated Trade Setups - newser.com
Can GeoVax Labs Inc. Equity Warrant stock hit analyst price targetsStock Surge & Reliable Price Breakout Signals - newser.com
What technical charts say about GeoVax Labs Inc. stockBreakout Watch & Step-by-Step Swing Trade Plans - newser.com
Why GeoVax Labs Inc. stock is seen as undervaluedWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Can GeoVax Labs Inc. stock hit record highs againJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Relative strength of GeoVax Labs Inc. Equity Warrant in sector analysisPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Custom watchlist performance reports with GeoVax Labs Inc.Dividend Hike & Safe Capital Growth Stock Tips - newser.com
Combining machine learning predictions for GeoVax Labs Inc. Equity WarrantJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Published on: 2025-11-19 17:57:21 - newser.com
How risky is GeoVax Labs Inc. Equity Warrant stock nowWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Real time breakdown of GeoVax Labs Inc. stock performanceQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Is now a turning point for GeoVax Labs Inc.July 2025 Trends & Community Consensus Picks - newser.com
Best data tools to analyze GeoVax Labs Inc. Equity Warrant stockWeekly Trade Report & Capital Efficient Trading Techniques - newser.com
Published on: 2025-11-19 13:22:17 - newser.com
D. Boral Capital Maintains GeoVax Labs (GOVX) Buy Recommendation - Nasdaq
Can technical indicators confirm GeoVax Labs Inc. Equity Warrant’s reversalRisk Management & Weekly Top Performers Watchlists - newser.com
GOVX Analyst Update: Price Target Lowered by Jason Kolbert | GOV - GuruFocus
Has GeoVax Labs Inc. found a price floorEntry Point & Precise Buy Zone Identification - newser.com
How to forecast GeoVax Labs Inc. trends using time series2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-19 00:56:36 - newser.com
How GeoVax Labs Inc. Equity Warrant stock benefits from global expansionOptions Play & Weekly Chart Analysis and Guides - newser.com
Tools to monitor GeoVax Labs Inc. Equity Warrant recovery probabilityBuy Signal & Expert Approved Momentum Trade Ideas - newser.com
Is GeoVax Labs Inc. stock supported by strong fundamentalsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and 4D Molecular Therapeutics (FDMT) - The Globe and Mail
Its Stock Has Paid Off Big Time For Geovax Labs Inc - Setenews
Candlestick signals on GeoVax Labs Inc. Equity Warrant stock todayJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geovax Labs Inc Stock (GOVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):